TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 22145
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 20235
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 1287
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 12194
 
  
 
C07K PEPTIDES 11125
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 10115
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 990
 
  
 
A61B DIAGNOSIS; SURGERY; IDENTIFICATION 5235
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 346
 
  
 
A01K ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS147

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0357,750 METHOD FOR EVALUATING DRUG SENSITIVITY AND DISEASE VULNERABILITY BY ANALYZING CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN GENEJul 10, 17Dec 14, 17[C12Q, G06F]
2017/0333,549 Hemagglutinin-Binding PeptideOct 23, 15Nov 23, 17[A61K, C07K]
2016/0073,936 MOTOR FUNCTION ANALYSIS SYSTEM AND OPERATIONAL METHOD OF SYSTEMApr 30, 14Mar 17, 16[A61B]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9891228 Method for determining ubiquitin chain lengthNov 05, 14Feb 13, 18[G01N, C07K]
9891229 Method for determining ubiquitin chain lengthSep 21, 17Feb 13, 18[G01N, C07K]
9802992 Cell into which protein, which can serve as polymerization nucleus of protein polymer, or polymer thereof is introduced, and method for production of the cellDec 06, 06Oct 31, 17[C12N, G01N, C07K]
9804174 Biomarker for parkinson's disease and use thereofFeb 13, 15Oct 31, 17[A61K, C12Q, G01N, C07K]
9727691 Method for evaluating drug sensitivity and disease vulnerability by analyzing cyclic AMP responsive element binding protein geneOct 01, 12Aug 08, 17[C12Q, G06F]
9632092 Reagent for diagnosing tumor, pharmaceutical composition, and screening methodJul 09, 15Apr 25, 17[C12Q, G01N, C07K]
9624279 Method for producing insoluble aggregate of neurodegenerative-disease-related proteinMay 18, 12Apr 18, 17[C12P, G01N, C07K]
9315790 Polynucleotides encoding proteins having acquired α-galactosidase activitySep 13, 13Apr 19, 16[A61K, C12N]
9193964 Highly functional enzyme having alpha-galactosidase activityJan 23, 14Nov 24, 15[A61K, C07H, C12P, C12N, C07K]
9175269 Modified human hepatitis C virus genomic RNA that can be autonomously replicatedJan 04, 13Nov 03, 15[A61K, C12Q, C12N]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2014/0219,988 RRECOMBINANT HUMAN SAPOSIN B PROTEIN CONTAINING PHOSPHORYLATED GLUCOSE RING AND USE THEREOFAbandonedNov 21, 11Aug 07, 14[A61K, C07K]
2014/0178,856 POLYNUCLEOTIDE DERIVED FROM NOVEL HEPATITIS C VIRUS STRAIN AND USE THEREOFAbandonedNov 13, 13Jun 26, 14[C12Q]
8660641 Method for identifying and evaluating parallel motor control function in the brain based on electromyogram signalsExpiredSep 15, 10Feb 25, 14[A61B]
8609403 Polynucleotide derived from novel hepatitis C virus strain and use thereofExpiredAug 25, 10Dec 17, 13[C12N]
8604179 Nucleic acid comprising chimeric gene derived from hepatitis C virusExpiredApr 24, 09Dec 10, 13[A61K, C12N, C07K]
2013/0288,338 RECOMBINANT VACCINIA VIRUS HAVING HEMAGGLUTININ PROTEIN GENES DERIVED FROM NOVEL INFLUENZA VIRUSESAbandonedOct 13, 11Oct 31, 13[A61K]
2013/0190,240 TUMOR GROWTH CONTROLLING METHOD TARGETING GALACTOSYLCERAMIDE EXPRESSION FACTOR-1AbandonedJun 24, 11Jul 25, 13[C07K]
2013/0129,738 PHARMACEUTICAL COMPOSITIONAbandonedNov 19, 10May 23, 13[A61K, C07K]
2012/0251,572 HEPATITIS C VIRUS VACCINE COMPOSITIONAbandonedSep 30, 10Oct 04, 12[A61K, A61P]
2012/0245,050 BIOMARKER FOR PREDICTING THERAPEUTIC EFFICACY OF ALLERGEN IMMUNOTHERAPYAbandonedOct 25, 10Sep 27, 12[C40B]
2012/0115,927 PHARMACEUTICAL AGENT FOR PREVENTING CELL DEATHAbandonedMar 23, 10May 10, 12[A61K, A61P]
8143022 High production system for infectious hepatitis C virus particleExpiredSep 29, 06Mar 27, 12[C12P, C12N]
2012/0014,987 DNA VACCINE FOR ALZHEIMER'S DISEASEAbandonedMar 26, 10Jan 19, 12[A61K, C12N, A61P]
2011/0189,690 ANTIBODY COMPLEX, METHOD FOR DETECTING ANTIGEN, AND METHOD FOR PRODUCING ANITBODY COMPLEXAbandonedJun 30, 09Aug 04, 11[C12Q, C07K]
2011/0020,347 ANTI-BRAK (CXCL14) HUMAN MONOCLONAL ANTIBODY AND USE THEREOFAbandonedFeb 12, 08Jan 27, 11[A61K, C12P, C12N, G01N, A61P, C07K]
2010/0278,865 PRODUCTION AND USE OF EPITOPE-TAGGED HEPATITIS C VIRUS PARTICLEAbandonedJul 11, 08Nov 04, 10[A61K, C07H, C12N, A61P, C07K]
2010/0240,552 METHOD FOR EVALUATION OF DRUG SENSITIVITY BY ANALYSIS OF POMC GENEAbandonedApr 25, 08Sep 23, 10[C07H, C12Q, C40B]
2009/0297,592 Lipid Vesicle CompositionAbandonedMay 11, 06Dec 03, 09[A61K, A61P]
7579166 Glycoprotein and process for producing the sameExpiredJun 14, 02Aug 25, 09[C12Q, C12P, C12N, C07K]
7227052 GFP expression vector localized in mitochondriaExpiredSep 29, 01Jun 05, 07[A01K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.